{
  "chapter": "Glycogen metabolism and glycogen storage disorders",
  "questions": [
    {
      "q_no": 1,
      "question": "Question 1: Which of the following pairs correctly represents the primary glycosidic bond linkage and the \nbranch-point bond linkage in glycogen, respectively?",
      "options": {
        "a": "(1 4) linkage; (1 6) linkage",
        "b": " (1 6) linkage;  (1 4) linkage",
        "c": " (1 4) linkage;  (1 4) linkage",
        "d": " (1 6) linkage; (1 6) linkage"
      },
      "correct_answer": "a",
      "explanation": "In glycogen, the primary glycosidic bond is an  (1 4) linkage, whereas the branch point contains \nan  (1 6) linkage. Glycogen is a branched-chain homopolysaccharide with -D-glucose being the monosaccharide, \nits major constituent.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 2,
      "question": "Question 2: In which of the following organs does glycogen synthesis takes place?",
      "options": {
        "a": "Liver and kidney",
        "b": "Liver and muscle",
        "c": "Muscle and RBC",
        "d": "Muscle and kidney"
      },
      "correct_answer": "b",
      "explanation": "Glycogenesis takes place majorly in the skeletal muscle and the liver. Glycogen functions as the secondary long-term energy storage, with the primary energy stores \nbeing fats held in adipose tissue. Glucose 6-phosphate derived from glycogen breakdown can • Be used as a fuel for glycolysis in muscles • Be converted into free glucose in the liver and subsequently released into the blood • Enter into the pentose phosphate pathway to generate NADPH or ribose in a variety of tissues 51 \nSold by @itachibot",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 3,
      "question": "Question 3: Where does the process of glycogen synthesis take place?",
      "options": {
        "a": "Mitochondria",
        "b": "Golgi apparatus",
        "c": "Cytosol",
        "d": "Endoplasmic reticulum"
      },
      "correct_answer": "c",
      "explanation": "The process of glycogen synthesis takes place within the cytosol of skeletal muscle and liver, \nwhere it is stored in the hydrated form with three or four parts of water.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 4,
      "question": "Question 4: Which of the following is a primer acting as an acceptor of glucose residues in the process of \nglycogen synthesis?",
      "options": {
        "a": "Protein",
        "b": "Carbohydrate",
        "c": "Lipid",
        "d": "Nucleic acid"
      },
      "correct_answer": "a",
      "explanation": "A protein named glycogenin is the primer acting as an acceptor of glucose residues in the process \nof glycogen synthesis. The ensuing entity is glycosylated further by UDP-glucose. Glycogenin further catalyzes the \ntransfer of seven glucose residues from UDP-Glucose, in 1  4 linkages, to form a glycogen \nprimer. This in turn serves as the substrate for the enzyme, glycogen synthase, which is the \nrate-limiting enzyme of glycogen synthesis.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 5,
      "question": "Question 5: Glucose attached to which of the following serves as the donor source of glucose in the \nprocess of glycogen synthesis?",
      "options": {
        "a": "UDP",
        "b": "ITP",
        "c": "ATP",
        "d": "GTP"
      },
      "correct_answer": "a",
      "explanation": "-D-Glucose attached to uridine diphosphate (UDP) serves as the source of glucose, \nwhich is added to the glycogen molecule. UDP-glucose is, in turn, synthesized from glucose 1-phosphate and UTP by the enzyme \nUDP-glucose pyrophosphorylase.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 6,
      "question": "Question 6: Which of the following depicts the correct sequence of enzymes involved in glycogenolysis in \nthe liver?",
      "options": {
        "a": "Phosphorylase, Glucan transferase, Glucose-6-phosphatase",
        "b": "Glycogen synthase, Phosphorylase, Glucose-6-phosphatase",
        "c": "Glucose-6-phosphatase, Phosphorylase, Debranching enzyme",
        "d": "Phosphorylase, Glucose-6-phosphatase, Glucan transferase"
      },
      "correct_answer": "a",
      "explanation": "52 \nSold by @itachibot The sequence of enzymes involved in steps of glycogenolysis is phosphorylase, glucan transferase, \nand glucose-6-phosphatase.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 7,
      "question": "Question 7: Which of the following enzymes catalyze the rate-limiting step of glycogenolysis?",
      "options": {
        "a": "Glycogen synthase",
        "b": "Glycogen phosphorylase",
        "c": "Glucose 6 Phosphatase",
        "d": "Phosphoglucomutase"
      },
      "correct_answer": "b",
      "explanation": "The rate-limiting step in glycogenolysis is catalyzed by the enzyme, glycogen phosphorylase. The process of phosphorolytic cleavage of the 1  4 linkages of glycogen to yield single units of \nglucose 1-phosphate, is catalyzed by the enzyme glycogen phosphorylase. Glycogen phosphorylase requires pyridoxal phosphate as the coenzyme The phosphate group is \ncatalytically active. There are different isoenzymes of glycogen phosphorylase in the liver, muscle, \nand brain.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 8,
      "question": "Question 8: Muscle cannot release glucose from glycogen because of the deficiency of which of the \nfollowing enzymes? 46 \nSold by @itachibot",
      "options": {
        "a": "Glucokinase",
        "b": "Phosphoglucomutase",
        "c": "Glucose-6-phosphatase",
        "d": "Muscle phosphorylase"
      },
      "correct_answer": "c",
      "explanation": "Muscles cannot release glucose into the blood due to the absence of the enzyme \nglucose-6-phosphatase. Glucose-6-phosphatase is present in the lumen of the smooth endoplasmic reticulum of \nhepatocytes. Hence, hepatocytes can convert glucose-6-phosphate into glucose and release \nglycogen-derived glucose into the blood in order to maintain blood glucose levels stable, until \ngluconeogenesis kicks in. However, myocytes lack the enzyme glucose 6-phosphatase. As a result, glucose-6-phosphate \ncannot be dephosphorylated and released into the blood. Muscle glycogen provides a readily \navailable source of glucose-1-phosphate for glycolysis within the muscle itself. Defects in the enzyme or glucose-6-phosphate transporter (GLUT 7) can cause type I glycogen \nstorage disease.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 9,
      "question": "Question 9: Which of the following vitamins serves as the cofactor of the enzyme glycogen \nphosphorylase?",
      "options": {
        "a": "Vitamin B1",
        "b": "Vitamin B6",
        "c": "Vitamin B2",
        "d": "VItamin B7"
      },
      "correct_answer": "b",
      "explanation": "Glycogen phosphorylase requires pyridoxal phosphate, i.e., vitamin B6, as its coenzyme. The process of phosphorolytic cleavage of the 1  4 linkages of glycogen to yield single units of \nglucose 1-phosphate, is catalyzed by the enzyme glycogen phosphorylase.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 10,
      "question": "Question 10: Which of the following is an allosteric activator of muscle glycogen phosphorylase?",
      "options": {
        "a": "ATP",
        "b": "Insulin",
        "c": "Glucose",
        "d": "5'AMP"
      },
      "correct_answer": "d",
      "explanation": "5'AMP serves as the allosteric activator of muscle glycogen phosphorylase. Glycogen phosphorylase catalyzes the rate-limiting step in glycogenolysis. It is regulated by \nallosteric mechanisms and covalent modification by reversible phosphorylation and \ndephosphorylation in response to hormone action. 53 \nSold by @itachibot In both liver and muscle, the glycogen phosphorylase is: • Activated by phosphorylation catalyzed by phosphorylase kinase (to yield phosphorylase a) • Inactivated by dephosphorylation catalyzed by protein phosphatase-1 (to yield phosphorylase b) Muscle phosphorylase differs from the liver isoenzyme in having a binding site for 5 AMP. It acts \nas an allosteric activator of the (inactive) dephosphorylated b-form of the enzyme. Allosteric Activator \nAllosteric Inhibitor Liver \nATPGlucose-6-phosphateFre \ne glucose 5' AMP \nATPGlucose-6-phosphate Musc \nle",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 11,
      "question": "Question 11: Which of the following do not take part in regulating the enzyme glycogen phosphorylase?",
      "options": {
        "a": "cAMP",
        "b": "Calmodulin",
        "c": "Protein phosphatase-1",
        "d": "Glycogenin"
      },
      "correct_answer": "d",
      "explanation": "Glycogenin cannot regulate glycogen phosphorylase enzyme. It is a polypeptide serving as a \nprimer in the initiation of glycogen synthesis. Regulation of glycogen metabolism at the level of glycogen phosphorylase: • cAMP activates phosphorylase kinase (by a cAMP-dependent protein kinase), which in turn \nactivates glycogen phosphorylase. • Calcium activates the calmodulin component of phosphorylase kinase directly, which in turn \nactivates glycogen phosphorylase. • 5' AMP acts allosterically to activate glycogen phosphorylase. • Protein phosphatase-1 inactivates glycogen phosphorylase. The regulation of glycogen phosphorylase is shown in the image below. 54 \nSold by @itachibot",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 12,
      "question": "Question 12: Which of the following is the debranching enzyme? 47 \nSold by @itachibot",
      "options": {
        "a": "Phosphogluconomutase",
        "b": "Glucose 6-phosphatase",
        "c": "Amylo 1,6 glucosidase",
        "d": "Amylo 1,4- 1,6 transglucosidase"
      },
      "correct_answer": "c",
      "explanation": "Amylo 1,6 glucosidase + (1,4)-&gt;(1,4) glucan transferase forms the debranching enzyme. When four glucose residues remain on either side of the branching point, (1,4)-&gt;(1,4) glucan \ntransferase transfers a trisaccharide unit from one branch of glycogen to the other following \nwhich, amylo 1,6-glucosidase catalyzes the hydrolysis of the (1,6) glycosidic bond to liberate free \nglucose.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 13,
      "question": "Question 13: Under anaerobic metabolism which of the following substrates yields 3 molecules of ATP?",
      "options": {
        "a": "Glycogen",
        "b": "Amino acid",
        "c": "Glucose",
        "d": "Galactose"
      },
      "correct_answer": "a",
      "explanation": "Breakdown of glycogen under anaerobic conditions yields 3 ATPs. Breakdown of glycogen yields glucose-6-phosphate which can enter the glycolysis pathway. Since \nit bypasses the first step, one ATP is saved and anaerobic glycolysis yields 3 ATPs. The first step in glycolysis involves the conversion of glucose to glucose-6-phosphate which \nrequires one ATP. Glycogen breakdown leads to formation of glucose-6-phosphate which can \nenter glycolysis hence bypassing the first step and saving one ATP. One ATP is used for conversion of fructose-6-phosphate to fructose 1,6 biphosphate hence net \nATP formed from anaerobic glycolysis of glycogen is 3ATP NET ATP PRO \nDUCED REACTION \nEN˜™ME \nMETHOD OF ATP FORMAT \nION 1,3-bisphosphoglycerate to 3 \nphosphoglycerate 2 ATP Phosphoglycerate kina \nse Substrate level phosphorylati \non 2 ATP Phosphoenol pyruvate to Pyr \nuvate Pyruvate kinase \nSubstrate level phosphorylati \non 55 \nSold by @itachibot NET ATP PRO \nDUCED REACTION \nEN˜™ME \nMETHOD OF ATP FORMAT \nION TOTAL PRODUCED \n4 ATP",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 14,
      "question": "Question 14: Which of the following is not a glycogen-storage disorder?",
      "options": {
        "a": "Her's Disease",
        "b": "Tarui's Disease",
        "c": "Scheie's Disease",
        "d": "Andersen's Disease"
      },
      "correct_answer": "c",
      "explanation": "Scheie's disease is not a glycogen-storage disease, it is a type of mucopolysaccharidosis.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 15,
      "question": "Question 15: Which of the following glycogen storage diseases is also a lysosomal storage disorder?",
      "options": {
        "a": "Von Gierke’s disease",
        "b": "Pompe’s disease",
        "c": "McArdle’s disease",
        "d": "Cori’s disease"
      },
      "correct_answer": "b",
      "explanation": "Pompe’s disease is the glycogen storage disease (GSD), which is also a lysosomal storage disorder. A small amount of glycogen is degraded by the lysosomal enzyme,  (1 4)-glucosidase also \nknown as acid maltase. A deficiency of this enzyme causes the accumulation of glycogen in \nvacuoles in the lysosomes. This is called type II GSD or Pompe’s disease. Glycogen storage disorders that are associated with the following findings: • Liver cirrhosis: Types III, IV, IX GSD • Renal dysfunction: Type I GSD • Neurologic involvement: Type II GSD Note: Another GSD that is also a lysosomal storage disorder is Danon disease (or glycogen storage \ndisease Type IIb)",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 16,
      "question": "Question 16: A 6-month-old baby was brought to the clinic with a history of failure to thrive. Further \nexamination shows generalized hypotonia and hepatomegaly. Chest X-ray image shows \nmassive cardiomegaly. Microscopy of a muscle biopsy is shown in the given image. Which of 48 \nSold by @itachibot the following is the treatment for this condition?",
      "options": {
        "a": "Naglazyme",
        "b": "Alglucosidase alfa",
        "c": "Aldurazyme",
        "d": "Elaprase"
      },
      "correct_answer": "b",
      "explanation": "56 \nSold by @itachibot The clinical symptoms of hypotonia, hepatomegaly, and cardiomegaly, along with muscle biopsy \nshowing vacuoles are suggestive of Pompe's disease. Pompe's disease (type II glycogen storage disorder) occurs due to a mutation in \nalpha-1,4-glucosidase (also known as acid maltase), a lysosomal enzyme. A defect in this enzyme \nleads to the accumulation of glycogen in the lysosomes of peripheral, voluntary muscles and \nprogresses to involve the cardiac muscle and diaphragm. Clinical features include hypotonia \n(floppy baby syndrome), cardiomyopathy, hepatomegaly, and failure to thrive. Myozyme The treatment for Pompe disease is recombinant enzyme alglucosidase alfa (Myozyme), which can \nprevent worsening or reverse cardiac and skeletal abnormalities.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxbiochemistry/Glycogen_metabolism_and_glycogen_storage_disorders_Q16_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 17,
      "question": "Question 17: A 10-year-old boy rapidly develops hypoglycemia after moderate activity. Blood examination \nreveals raised levels of ketone bodies, lactic acid, and triglycerides. On examination, the liver \nand kidneys are found to be enlarged. Histopathology of the liver shows deposits of glycogen \nin an excess amount. What is the diagnosis?",
      "options": {
        "a": "von Gierke’s disease",
        "b": "Pompe’s disease",
        "c": "McArdle’s disease",
        "d": "Cori’s disease"
      },
      "correct_answer": "a",
      "explanation": "The given features are consistent with von Gierke's disease. It is the most common glycogen \nstorage disease. Enzyme deficient in this condition is glucose-6-phosphatase (common to both glycogenolysis and \ngluconeogenesis). Inheritance is autosomal recessive. Von Gierke disease (type I glycogen storage disorder) occurs due to the deficiency of \nglucose-6-phosphatase enzyme in the liver, kidney, and intestinal mucosa. Patients present \ncommonly by 3-4 months of age with hypoglycemia (leading to seizures), lactic acidosis, and \nhepatomegaly. Affected children often have a doll-like face with fat cheeks, relatively thin \nextremities, short stature, and a protuberant abdomen due to massive hepatomegaly. The kidneys \nare also enlarged, whereas the spleen and heart are not involved. Laboratory findings include \nhypoglycemia, lactic acidosis, hyperuricemia, and hyperlipidemia. A definitive diagnosis is made using a liver biopsy. Fructose and galactose restriction in the diet is \nadvised.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 18,
      "question": "Question 18: After evaluation, a child with severe hypoglycemia, lactic acidosis, and hyperuricemia is \ndiagnosed with von Gierke’s disease. What is the inheritance pattern of this disease?",
      "options": {
        "a": "Autosomal dominant",
        "b": "Autosomal recessive",
        "c": "X-linked recessive",
        "d": "X-linked dominant"
      },
      "correct_answer": "b",
      "explanation": "Von Gierke’s disease is inherited as an autosomal recessive trait. Von Gierke disease (type I glycogen storage disorder) occurs due to the deficiency of \nglucose-6-phosphatase enzyme in the liver, kidney, and intestinal mucosa. Patients present \ncommonly by 3-4 months of age with hypoglycemia (leading to seizures), lactic acidosis, and \nhepatomegaly. Affected children often have a doll-like face with fat cheeks, relatively thin extremities, short \nstature, and a protuberant abdomen due to massive hepatomegaly. The kidneys are also enlarged, \nwhereas the spleen and heart are not involved. Laboratory findings include hypoglycemia, lactic \nacidosis, hyperuricemia, and hyperlipidemia.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 19,
      "question": "Question 19: A 3-year-old child presents with growth retardation and a history of recurrent attacks of \nhypoglycemia. On examination, you notice doll-like facies with relatively thin extremities and \nmassive hepatomegaly. Blood examination reveals increased lactic acid, triglyceride, and uric \nacid levels. All of the following complications can be expected in this child except:",
      "options": {
        "a": "Hepatic adenoma",
        "b": "Pancreatitis",
        "c": "Cardiomyopathy",
        "d": "Renal failure"
      },
      "correct_answer": "c",
      "explanation": "57 \nSold by @itachibot The most likely diagnosis in this clinical scenario is von Gierke’s disease. Cardiomyopathy is not a \ncomplication of von Gierke’s disease. On the contrary, cardiomyopathy is associated with Pompe's \ndisease. Enzyme deficient in von Gierke’s disease is glucose-6-phosphatase (common to both \nglycogenolysis and gluconeogenesis). Inheritance is autosomal recessive. Glycogen accumulation occurs in the liver and renal tubular cells. Clinical features include: • Severe hypoglycemia • Ketosis • Lactic acidosis • Hypertriglyceridemia • Hyperuricemia A definitive diagnosis is made using a liver biopsy. Fructose and galactose restriction in the diet is \nadvised. Complications of von Gierke's disease includes polycystic ovaries, osteopenia, hepatic adenoma, \npulmonary hypertension, pancreatitis and renal failure.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    },
    {
      "q_no": 20,
      "question": "Question 20: An adolescent male patient presented with pain in the calf muscles on exercise. On biopsy, an \nexcessive amount of glycogen was found to be present in the muscle. What is the most likely \nenzyme deficiency?",
      "options": {
        "a": "Fatty acid synthesis",
        "b": "Ketone synthesis",
        "c": "Adrenal cortex",
        "d": "Muscles"
      },
      "correct_answer": "d",
      "explanation": "The given clinical features are seen in McArdle's disease. This patient has muscle glycogen \nphosphorylase deficiency. The lack of muscle glycogen phosphorylase results in excess glycogen build-up in muscles. The \nimage given below shows the vacuolar myopathy seen in McArdle's disease. Clinical features include poor exercise tolerance, abnormally high muscle glycogen (2.5-4%), and a \nvery low blood lactate after exercise 58 \nSold by @itachibot The images given below show myophosphorylase enzyme histochemistry showing (A) Normal \nmuscle and (B) McArdle's disease. 59 \nSold by @itachibot HMP shunt pathway, Fructose , Galactose metabolism",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxbiochemistry/Glycogen_metabolism_and_glycogen_storage_disorders_Q20_q.jpg",
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxbiochemistry/Glycogen_metabolism_and_glycogen_storage_disorders_Q20_exp.jpg",
      "chapter_heading": "Glycogen metabolism and glycogen storage disorders"
    }
  ]
}
